{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:47:16Z","timestamp":1795085236044,"version":"4.10.2"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD), including nephrotic syndrome, is a major cause of cardiovascular morbidity and mortality. The literature indicates that CKD is associated with profound lipid disorders due to the dysregulation of lipoprotein metabolism which progresses kidney disease. The objective of this study is to evaluate the protective effects of curcumin on dyslipidaemia associated with adenine-induced chronic kidney disease in rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Male SD rats (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u200929) were divided into 5 groups for 24\u2009days: normal control (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20095, normal diet), CKD control (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20096, 0.75% w\/w adenine-supplemented diet), CUR 50 (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20096, 50\u2009mg\/kg\/day curcumin +\u20090.75% w\/w adenine-supplemented diet), CUR 100 (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20096, 100\u2009mg\/kg\/day curcumin +\u20090.75% w\/w adenine-supplemented diet), and CUR 150 (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20096, 150\u2009mg\/kg\/day curcumin +\u20090.75% w\/w adenine-supplemented diet). The serum and tissue lipid profile, as well as the kidney function test, were measured using commercial diagnostic kits.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The marked rise in total cholesterol, low-density lipoprotein (LDL) cholesterol, very low-density lipoprotein (VLDL) cholesterol, triglycerides and free fatty acids in serum, as well as hepatic cholesterol, triglyceride and free fatty acids of CKD control rats were significantly protected by curcumin co-treatment (at the dose of 50, 100 and 150\u2009mg\/kg). Furthermore, curcumin significantly increased the serum high-density lipoprotein (HDL) cholesterol compared to the CKD control rats but did not attenuate the CKD-induced weight retardation. Mathematical computational analysis revealed that curcumin significantly reduced indicators for the risk of atherosclerotic lesions (atherogenic index) and coronary atherogenesis (coronary risk index). In addition, curcumin improved kidney function as shown by the reduction in proteinuria and improvement in creatinine clearance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results provide new scientific evidence for the use of curcumin in CKD-associated dyslipidaemia and substantiates the traditional use of curcumin in preventing kidney damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-019-1621-6","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T12:03:49Z","timestamp":1574337829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Chronic treatment of curcumin improves hepatic lipid metabolism and alleviates the renal damage in adenine-induced chronic kidney disease in Sprague-Dawley rats"],"prefix":"10.1186","volume":"20","author":[{"given":"Hardik","family":"Ghelani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Razmovski-Naumovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-2789","authenticated-orcid":false,"given":"Srinivas","family":"Nammi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"issue":"4","key":"1621_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1053\/ajkd.2002.31990","volume":"39","author":"HS Trivedi","year":"2002","unstructured":"Trivedi HS, Pang MM, Campbell A, Saab P. Slowing the progression of chronic renal failure: economic benefits and patients' perspectives. Am J Kidney Dis. 2002;39(4):721\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1621_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1523-1755.2005.09800.x","volume":"98","author":"JH Dirks","year":"2005","unstructured":"Dirks JH, de Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, et al. Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl. 2005;98:S1\u20136.","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"1621_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/MNH.0b013e328327b360","volume":"18","author":"S Yamamoto","year":"2009","unstructured":"Yamamoto S, Kon V. Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr Opin Nephrol Hypertens. 2009;18(3):181\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"1621_CR4","doi-asserted-by":"publisher","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","volume":"290","author":"ND Vaziri","year":"2006","unstructured":"Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006;290(2):F262\u201372.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"1621_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1542-4758.2006.01168.x","volume":"10","author":"ND Vaziri","year":"2006","unstructured":"Vaziri ND, Moradi H. Mechanisms of dyslipidemia of chronic renal failure. Hemodial Int. 2006;10(1):1\u20137.","journal-title":"Hemodial Int"},{"issue":"2","key":"1621_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10157-013-0847-z","volume":"18","author":"ND Vaziri","year":"2014","unstructured":"Vaziri ND. Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease. Clin Exp Nephrol. 2014;18(2):265\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"1621_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000488816","volume":"46","author":"MC Bulbul","year":"2018","unstructured":"Bulbul MC, Dagel T, Afsar B, Ulusu NN, Kuwabara M, Covic A, Kanbay M. Disorders of lipid metabolism in chronic kidney disease. Blood Purifi. 2018;46(2):144\u201352.","journal-title":"Blood Purifi"},{"issue":"2","key":"1621_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055643","volume":"8","author":"S-C Chen","year":"2013","unstructured":"Chen S-C, Hung C-C, Kuo M-C, Lee J-J, Chiu Y-W, Chang J-M, Hwang S-J, Chen H-C. Association of Dyslipidemia with renal outcomes in chronic kidney disease. PLoS One. 2013;8(2):e55643.","journal-title":"PLoS One"},{"issue":"25","key":"1621_CR9","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.jacc.2008.03.025","volume":"51","author":"CR Harper","year":"2008","unstructured":"Harper CR, Jacobson TA. Managing dyslipidemia in chronic kidney disease. J Am Coll Cardiol. 2008;51(25):2375\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1621_CR10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1525-1497.2004.40049.x","volume":"19","author":"DE Weiner","year":"2004","unstructured":"Weiner DE, Sarnak MJ. Managing dyslipidemia in chronic kidney disease. J Gen Intern Med. 2004;19(10):1045\u201352.","journal-title":"J Gen Intern Med"},{"issue":"12","key":"1621_CR11","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/ndt\/15.12.1993","volume":"15","author":"N Broeders","year":"2000","unstructured":"Broeders N, Knoop C, Antoine M, Tielemans C, Abramowicz D. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent? Nephrol Dial Transplant. 2000;15(12):1993\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1621_CR12","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3109\/08860221003753323","volume":"32","author":"MH Ahmed","year":"2010","unstructured":"Ahmed MH. Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials. Ren Fail. 2010;32(5):642\u20136.","journal-title":"Ren Fail"},{"issue":"3","key":"1621_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.vascn.2013.05.001","volume":"68","author":"BH Ali","year":"2013","unstructured":"Ali BH, Al-Salam S, Al Za'abi M, Waly MI, Ramkumar A, Beegam S, et al. New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats. J Pharmacol Toxicol Methods. 2013;68(3):384\u201393.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"1\u20132","key":"1621_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-013-1788-2","volume":"384","author":"J Manivannan","year":"2013","unstructured":"Manivannan J, Balamurugan E, Silambarasan T, Raja B. Diosgenin improves vascular function by increasing aortic eNOS expression, normalize dyslipidemia and ACE activity in chronic renal failure rats. Mol Cell Biochem. 2013;384(1\u20132):113\u201320.","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"1621_CR15","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1021\/jf030258j","volume":"52","author":"T Nakagawa","year":"2004","unstructured":"Nakagawa T, Yokozawa T, Sano M, Takeuchi S, Kim M, Minamoto S. Activity of (Tveden-Nyborg et al.)-epigallocatechin 3-O-gallate against oxidative stress in rats with adenine-induced renal failure. J Agric Food Chem. 2004;52(7):2103\u20137.","journal-title":"J Agric Food Chem"},{"issue":"1A","key":"1621_CR16","first-page":"363","volume":"23","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23(1A):363\u201398.","journal-title":"Anticancer Res"},{"key":"1621_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2210-5-15","volume":"5","author":"N Tirkey","year":"2005","unstructured":"Tirkey N, Kaur G, Vij G, Chopra K. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol. 2005;5:15.","journal-title":"BMC Pharmacol"},{"issue":"9","key":"1621_CR18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.fct.2006.05.005","volume":"44","author":"EO Farombi","year":"2006","unstructured":"Farombi EO, Ekor M. Curcumin attenuates gentamicin-induced renal oxidative damage in rats. Food Chem Toxicol. 2006;44(9):1443\u20138.","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"1621_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1472-8206.2005.00343.x","volume":"19","author":"BH Ali","year":"2005","unstructured":"Ali BH, Al-Wabel N, Mahmoud O, Mousa HM, Hashad M. Curcumin has a palliative action on gentamicin-induced nephrotoxicity in rats. Fundam Clin Pharmacol. 2005;19(4):473\u20137.","journal-title":"Fundam Clin Pharmacol"},{"issue":"2\u20133","key":"1621_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ejphar.2011.08.037","volume":"670","author":"R Manikandan","year":"2011","unstructured":"Manikandan R, Beulaja M, Thiagarajan R, Priyadarsini A, Saravanan R, Arumugam M. Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats. Eur J Pharmacol. 2011;670(2\u20133):578\u201385.","journal-title":"Eur J Pharmacol"},{"issue":"25","key":"1621_CR21","doi-asserted-by":"publisher","first-page":"10150","DOI":"10.1021\/jf0723965","volume":"55","author":"A Kuhad","year":"2007","unstructured":"Kuhad A, Pilkhwal S, Sharma S, Tirkey N, Chopra K. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem. 2007;55(25):10150\u20135.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"1621_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/phrs.2000.0724","volume":"43","author":"LM Antunes","year":"2001","unstructured":"Antunes LM, Darin JD, Bianchi NL. Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res. 2001;43(2):145\u201350.","journal-title":"Pharmacol Res"},{"issue":"5","key":"1621_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jbiosc.2012.11.007","volume":"115","author":"M Ueki","year":"2013","unstructured":"Ueki M, Ueno M, Morishita J, Maekawa N. Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice. J Biosci Bioeng. 2013;115(5):547\u201351.","journal-title":"J Biosci Bioeng"},{"issue":"8","key":"1621_CR24","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/jn\/131.8.2090","volume":"131","author":"K Okada","year":"2001","unstructured":"Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr. 2001;131(8):2090\u20135.","journal-title":"J Nutr"},{"issue":"2","key":"1621_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.bjp.0703067","volume":"129","author":"N Venkatesan","year":"2000","unstructured":"Venkatesan N, Punithavathi D, Arumugam V. Curcumin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol. 2000;129(2):231\u20134.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1621_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1742-7843.2006.pto_503.x","volume":"99","author":"L Pari","year":"2006","unstructured":"Pari L, Murugan P. Tetrahydrocurcumin: effect on chloroquine-mediated oxidative damage in rat kidney. Basic Clin Pharmacol Toxicol. 2006;99(5):329\u201334.","journal-title":"Basic Clin Pharmacol Toxicol."},{"issue":"11","key":"1621_CR27","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3109\/10715762.2014.954109","volume":"48","author":"E Tapia","year":"2014","unstructured":"Tapia E, Sanchez-Lozada LG, Garcia-Nino WR, Garcia E, Cerecedo A, Garcia-Arroyo FE, et al. Curcumin prevents maleate-induced nephrotoxicity: relation to hemodynamic alterations, oxidative stress, mitochondrial oxygen consumption and activity of respiratory complex I. Free Radic Res. 2014;48(11):1342\u201354.","journal-title":"Free Radic Res"},{"issue":"3","key":"1621_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00240-009-0186-4","volume":"37","author":"M Bas","year":"2009","unstructured":"Bas M, Tugcu V, Kemahli E, Ozbek E, Uhri M, Altug T, Tasci AI. Curcumin prevents shock-wave lithotripsy-induced renal injury through inhibition of nuclear factor kappa-B and inducible nitric oxide synthase activity in rats. Urol Res. 2009;37(3):159\u201364.","journal-title":"Urol Res"},{"issue":"4","key":"1621_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12291-010-0046-6","volume":"25","author":"L Samanta","year":"2010","unstructured":"Samanta L, Panigrahi J, Bhanja S, Chainy GBN. Effect of turmeric and its active principle Curcumin on T(3)-induced oxidative stress and hyperplasia in rat kidney: a comparison. Indian J Clin Biochem. 2010;25(4):393\u20137.","journal-title":"Indian J Clin Biochem"},{"issue":"3","key":"1621_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12011-011-9194-7","volume":"145","author":"SF Nabavi","year":"2012","unstructured":"Nabavi SF, Moghaddam AH, Eslami S, Nabavi SM. Protective effects of curcumin against sodium fluoride-induced toxicity in rat kidneys. Biol Trace Elem Res. 2012;145(3):369\u201374.","journal-title":"Biol Trace Elem Res"},{"issue":"8","key":"1621_CR31","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.freeradbiomed.2011.07.018","volume":"51","author":"E Molina-Jijon","year":"2011","unstructured":"Molina-Jijon E, Tapia E, Zazueta C, El Hafidi M, Zatarain-Barron ZL, Hernandez-Pando R, et al. Curcumin prevents Cr (VI)-induced renal oxidant damage by a mitochondrial pathway. Free Radic Biol Med. 2011;51(8):1543\u201357.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1621_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.toxlet.2004.02.019","volume":"151","author":"V Eybl","year":"2004","unstructured":"Eybl V, Kotyzova D, Bludovska M. The effect of curcumin on cadmium-induced oxidative damage and trace elements level in the liver of rats and mice. Toxicol Lett. 2004;151(1):79\u201385.","journal-title":"Toxicol Lett"},{"issue":"5","key":"1621_CR33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jat.1517","volume":"30","author":"R Agarwal","year":"2010","unstructured":"Agarwal R, Goel SK, Behari JR. Detoxification and antioxidant effects of curcumin in rats experimentally exposed to mercury. J Appl Toxicol. 2010;30(5):457\u201368.","journal-title":"J Appl Toxicol"},{"issue":"5","key":"1621_CR34","doi-asserted-by":"publisher","first-page":"F1146","DOI":"10.1152\/ajprenal.90732.2008","volume":"296","author":"SS Ghosh","year":"2009","unstructured":"Ghosh SS, Massey HD, Krieg R, Fazelbhoy ZA, Ghosh S, Sica DA, et al. Curcumin ameliorates renal failure in 5\/6 nephrectomized rats: role of inflammation. Am J Physiol Renal Physiol. 2009;296(5):F1146\u201357.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"4","key":"1621_CR35","doi-asserted-by":"publisher","first-page":"F439","DOI":"10.1152\/ajprenal.00356.2010","volume":"302","author":"SS Ghosh","year":"2012","unstructured":"Ghosh SS, Krieg R, Massey HD, Sica DA, Fakhry I, Ghosh S, et al. Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5\/6 nephrectomized rats: role of phospholipase and cyclooxygenase. Am J Physiol Renal Physiol. 2012;302(4):F439\u201354.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3\u20134","key":"1621_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.phymed.2012.11.014","volume":"20","author":"E Tapia","year":"2013","unstructured":"Tapia E, Zatarain-Barron ZL, Hernandez-Pando R, Zarco-Marquez G, Molina-Jijon E, Cristobal-Garcia M, et al. Curcumin reverses glomerular hemodynamic alterations and oxidant stress in 5\/6 nephrectomized rats. Phytomedicine. 2013;20(3\u20134):359\u201366.","journal-title":"Phytomedicine."},{"key":"1621_CR37","doi-asserted-by":"publisher","first-page":"269039","DOI":"10.1155\/2012\/269039","volume":"2012","author":"E Tapia","year":"2012","unstructured":"Tapia E, Soto V, Ortiz-Vega KM, Zarco-Marquez G, Molina-Jijon E, Cristobal-Garcia M, et al. Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5\/6 nephrectomized rats. Oxidative Med Cell Longev. 2012;2012:269039.","journal-title":"Oxidative Med Cell Longev"},{"issue":"9","key":"1621_CR38","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/mnfr.201200540","volume":"57","author":"V Soetikno","year":"2013","unstructured":"Soetikno V, Sari FR, Lakshmanan AP, Arumugam S, Harima M, Suzuki K, et al. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Mol Nutr Food Res. 2013;57(9):1649\u201359.","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"1621_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1742-7843.2007.00109.x","volume":"101","author":"P Murugan","year":"2007","unstructured":"Murugan P, Pari L. Influence of tetrahydrocurcumin on hepatic and renal functional markers and protein levels in experimental type 2 diabetic rats. Basic Clin Pharmacol Toxicol. 2007;101(4):241\u20135.","journal-title":"Basic Clin Pharmacol Toxicol."},{"issue":"9","key":"1621_CR40","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.nut.2008.12.007","volume":"25","author":"J Chiu","year":"2009","unstructured":"Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition. 2009;25(9):964\u201372.","journal-title":"Nutrition."},{"issue":"11","key":"1621_CR41","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mnfr.201100080","volume":"55","author":"V Soetikno","year":"2011","unstructured":"Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, et al. Curcumin attenuates diabetic nephropathy by inhibiting PKC-alpha and PKC-beta1 activity in streptozotocin-induced type I diabetic rats. Mol Nutr Food Res. 2011;55(11):1655\u201365.","journal-title":"Mol Nutr Food Res"},{"issue":"10","key":"1621_CR42","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.1440-1681.2006.04468.x","volume":"33","author":"S Sharma","year":"2006","unstructured":"Sharma S, Kulkarni SK, Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol. 2006;33(10):940\u20135.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"1621_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00345-008-0253-4","volume":"26","author":"O Bayrak","year":"2008","unstructured":"Bayrak O, Uz E, Bayrak R, Turgut F, Atmaca AF, Sahin S, et al. Curcumin protects against ischemia\/reperfusion injury in rat kidneys. World J Urol. 2008;26(3):285\u201391.","journal-title":"World J Urol"},{"issue":"4","key":"1621_CR44","doi-asserted-by":"publisher","first-page":"H975","DOI":"10.1152\/ajpheart.00154.2010","volume":"299","author":"SS Ghosh","year":"2010","unstructured":"Ghosh SS, Salloum FN, Abbate A, Krieg R, Sica DA, Gehr TW, et al. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats. Am J Physiol Heart Circ Physiol. 2010;299(4):H975\u201384.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1621_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2013.03.017","volume":"61","author":"F Correa","year":"2013","unstructured":"Correa F, Buelna-Chontal M, Hernandez-Resendiz S, Garcia-Nino WR, Roldan FJ, Soto V, et al. Curcumin maintains cardiac and mitochondrial function in chronic kidney disease. Free Radic Biol Med. 2013;61:119\u201329.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1621_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10557-015-6581-x","volume":"29","author":"S Hernandez-Resendiz","year":"2015","unstructured":"Hernandez-Resendiz S, Correa F, Garcia-Nino WR, Buelna-Chontal M, Roldan FJ, Ramirez-Camacho I, et al. Cardioprotection by curcumin post-treatment in rats with established chronic kidney disease. Cardiovasc Drugs Ther. 2015;29(2):111\u201320.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"1621_CR47","first-page":"6019","volume":"8","author":"AM El-Mahalaway","year":"2015","unstructured":"El-Mahalaway AM. Protective effect of curcumin against experimentally induced aflatoxicosis on the renal cortex of adult male albino rats: a histological and immunohisochemical study. Int J Clin Exp Pathol. 2015;8(6):6019\u201330.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"1621_CR48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/imm.12079","volume":"139","author":"A Jacob","year":"2013","unstructured":"Jacob A, Chaves L, Eadon MT, Chang A, Quigg RJ, Alexander JJ. Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice. Immunology. 2013;139(3):328\u201337.","journal-title":"Immunology."},{"issue":"5","key":"1621_CR49","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3109\/0886022X.2011.577546","volume":"33","author":"MI Waly","year":"2011","unstructured":"Waly MI, Al Moundhri MS, Ali BH. Effect of curcumin on cisplatin- and oxaliplatin-induced oxidative stress in human embryonic kidney (HEK) 293 cells. Ren Fail. 2011;33(5):518\u201323.","journal-title":"Ren Fail"},{"issue":"1","key":"1621_CR50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1523-1755.2004.00713.x","volume":"66","author":"J Gaedeke","year":"2004","unstructured":"Gaedeke J, Noble NA, Border WA. Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int. 2004;66(1):112\u201320.","journal-title":"Kidney Int"},{"issue":"1","key":"1621_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/biof.1072","volume":"39","author":"JM Zingg","year":"2013","unstructured":"Zingg JM, Hasan ST, Meydani M. Molecular mechanisms of hypolipidemic effects of curcumin. Biofactors. 2013;39(1):101\u201321.","journal-title":"Biofactors."},{"issue":"4","key":"1621_CR52","first-page":"273","volume":"36","author":"KB Soni","year":"1992","unstructured":"Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. 1992;36(4):273\u20135.","journal-title":"Indian J Physiol Pharmacol"},{"issue":"4","key":"1621_CR53","first-page":"201","volume":"40","author":"I Alwi","year":"2008","unstructured":"Alwi I, Santoso T, Suyono S, Sutrisna B, Suyatna FD, Kresno SB, et al. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med Indones. 2008;40(4):201\u201310.","journal-title":"Acta Med Indones"},{"issue":"1","key":"1621_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/bcpt.12817","volume":"122","author":"BH Ali","year":"2018","unstructured":"Ali BH, Al-Salam S, Al Suleimani Y, Al Kalbani J, Al Bahlani S, Ashique M, et al. Curcumin ameliorates kidney function and oxidative stress in experimental chronic kidney disease. Basic Clin Pharmacol Toxicol. 2018;122(1):65\u201373.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"1621_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ilar.43.4.244","volume":"43","author":"MF Festing","year":"2002","unstructured":"Festing MF, Altman DG. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J. 2002;43(4):244\u201358.","journal-title":"ILAR J"},{"issue":"3","key":"1621_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.306","volume":"5","author":"H Ghelani","year":"2017","unstructured":"Ghelani H, Razmovski-Naumovski V, Nammi S. Chronic treatment of (R)-\u03b1-lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats. Pharmacol Res Perspect. 2017;5(3):e00306.","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"1621_CR57","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1472-8206.2005.00361.x","volume":"19","author":"O Wongmekiat","year":"2005","unstructured":"Wongmekiat O, Thamprasert K. Investigating the protective effects of aged garlic extract on cyclosporin-induced nephrotoxicity in rats. Fundam Clin Pharmacol. 2005;19(5):555\u201362.","journal-title":"Fundam Clin Pharmacol."},{"issue":"1","key":"1621_CR58","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0003-2697(78)90046-5","volume":"90","author":"A Hara","year":"1978","unstructured":"Hara A, Radin NS. Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem. 1978;90(1):420\u20136.","journal-title":"Anal Biochem"},{"issue":"3","key":"1621_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1258\/ebm.2009.009214","volume":"235","author":"BH Ali","year":"2010","unstructured":"Ali BH, Al-Salam S, Al Husseni I, Kayed RR, Al-Masroori N, Al-Harthi T, Al Zaabi M, Nemmar A. Effects of gum Arabic in rats with adenine-induced chronic renal failure. Exp Biol Med. 2010;235(3):373\u201382.","journal-title":"Exp Biol Med"},{"issue":"2","key":"1621_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1439-0272.1998.tb01157.x","volume":"30","author":"Y Adachi","year":"1998","unstructured":"Adachi Y, Sasagawa I, Tateno T, Tomaru M, Kubota Y, Nakada T. Influence of adenine-induced chronic renal failure on testicular function in the rat. Andrologia. 1998;30(2):115\u20138.","journal-title":"Andrologia."},{"issue":"4","key":"1621_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000454990","volume":"135","author":"N Florens","year":"2017","unstructured":"Florens N, Lemoine S, Pelletier CC, Rabeyrin M, Juillard L, Soulage CO. Adenine rich diet is not a surrogate of 5\/6 nephrectomy in rabbits. Nephron. 2017;135(4):307\u201314.","journal-title":"Nephron."},{"issue":"1","key":"1621_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2369-15-69","volume":"15","author":"GO Ferrari","year":"2014","unstructured":"Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, et al. Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5\/6 nephrectomy and adenine models. BMC Nephrol. 2014;15(1):69.","journal-title":"BMC Nephrol"},{"issue":"1","key":"1621_CR63","first-page":"48","volume":"23","author":"H Deng","year":"1998","unstructured":"Deng H, Jin W, Liao X, He Y. Methodology for designing pathological models of acute renal failure. Zhongguo Zhong Yao Za Zhi. 1998;23(1):48\u201352 64.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"3","key":"1621_CR64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1142\/S0192415X05003089","volume":"33","author":"HH Ngai","year":"2005","unstructured":"Ngai HH, Sit WH, Wan JM. The nephroprotective effects of the herbal medicine preparation, WH30+, on the chemical-induced acute and chronic renal failure in rats. Am J Chin Med. 2005;33(3):491\u2013500.","journal-title":"Am J Chin Med"},{"issue":"5","key":"1621_CR65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000072913","volume":"23","author":"K Ataka","year":"2003","unstructured":"Ataka K, Maruyama H, Neichi T, Miyazaki J, Gejyo F. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure. Am J Nephrol. 2003;23(5):315\u201323.","journal-title":"Am J Nephrol"},{"issue":"2","key":"1621_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10157-013-0847-z","volume":"18","author":"ND Vaziri","year":"2014","unstructured":"Vaziri ND. Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease. Clin Exp Nephrol. 2014;18(2):265\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"1621_CR67","doi-asserted-by":"publisher","first-page":"F539","DOI":"10.1152\/ajprenal.00074.2004","volume":"288","author":"K Liang","year":"2005","unstructured":"Liang K, Kim CH, Vaziri ND. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure. Am J Physiol Renal Physiol. 2005;288(3):F539\u201344.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1621_CR68","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/ki.1995.500","volume":"48","author":"ND Vaziri","year":"1995","unstructured":"Vaziri ND, Liang KH. Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis. Kidney Int. 1995;48(6):1979\u201385.","journal-title":"Kidney Int"},{"key":"1621_CR69","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/ki.1994.282","volume":"46","author":"WM Pandak","year":"1994","unstructured":"Pandak WM, Vlahcevic ZR, Heuman DM, Krieg RJ, Hanna JD, Chan JCM. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase and cholesterol 7\u03b1-hydroxylase in rats with subtotal nephrectomy. Kidney Intl. 1994;46:358\u201364.","journal-title":"Kidney Intl"},{"issue":"6","key":"1621_CR70","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/ndt\/13.6.1446","volume":"13","author":"MV Pahl","year":"1998","unstructured":"Pahl MV, Oveisi F, Khamiseh G, Vaziri ND. Intestinal absorption and biliary secretion of cholesterol in rats with nephrotic syndrome. Nephrol Dial Transplant. 1998;13(6):1446\u201351.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1621_CR71","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/ki.1996.388","volume":"50","author":"ND Vaziri","year":"1996","unstructured":"Vaziri ND, Liang KH. Down-regulation of hepatic LDL receptor expression in experimental nephrosis. Kidney Int. 1996;50(3):887\u201393.","journal-title":"Kidney Int"},{"issue":"5","key":"1621_CR72","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1046\/j.1523-1755.2003.00911.x","volume":"63","author":"ND Vaziri","year":"2003","unstructured":"Vaziri ND, Sato T, Liang K. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis. Kidney Int. 2003;63(5):1756\u201363.","journal-title":"Kidney Int"},{"key":"1621_CR73","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/ndt\/gft439","volume":"29","author":"S Liu","year":"2014","unstructured":"Liu S, Vaziri ND. Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome. Nephrol Dial Transplant. 2014;29:538\u201343.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1621_CR74","first-page":"Br228","volume":"11","author":"HM Arafa","year":"2005","unstructured":"Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit. 2005;11(7):Br228\u201334.","journal-title":"Med Sci Monit"},{"issue":"7","key":"1621_CR75","first-page":"534","volume":"46","author":"P Kapoor","year":"2008","unstructured":"Kapoor P, Ansari MN, Bhandari U. Modulatory effect of curcumin on methionine-induced hyperlipidemia and hyperhomocysteinemia in albino rats. Indian J Exp Biol. 2008;46(7):534\u201340.","journal-title":"Indian J Exp Biol"},{"issue":"2","key":"1621_CR76","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1089\/jmf.2011.1625","volume":"15","author":"TS Kam","year":"2012","unstructured":"Kam TS, Wong CY, Kwan PL, Fat-Yiu W, Chiu SM, Chan SW, et al. Effects and mechanism of turmeric vasorelaxation of the thoracic aorta in hypercholesterolemic rats. J Med Food. 2012;15(2):190\u20139.","journal-title":"J Med Food"},{"issue":"1\u20132","key":"1621_CR77","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1006819605211","volume":"166","author":"PS Babu","year":"1997","unstructured":"Babu PS, Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem. 1997;166(1\u20132):169\u201375.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"1621_CR78","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/mnfr.201100440","volume":"55","author":"SK Shin","year":"2011","unstructured":"Shin SK, Ha TY, McGregor RA, Choi MS. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res. 2011;55(12):1829\u201340.","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"1621_CR79","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/08860220701540326","volume":"29","author":"L Pari","year":"2007","unstructured":"Pari L, Murugan P. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail. 2007;29(7):881\u20139.","journal-title":"Ren Fail"},{"issue":"3","key":"1621_CR80","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4162\/nrp.2010.4.3.191","volume":"4","author":"M Kim","year":"2010","unstructured":"Kim M, Kim Y. Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet. Nutr Res Pract. 2010;4(3):191\u20135.","journal-title":"Nutr Res Pract"},{"issue":"1\u20132","key":"1621_CR81","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jep.2005.11.009","volume":"105","author":"C Fan","year":"2006","unstructured":"Fan C, Wo X, Qian Y, Yin J, Gao L. Effect of curcumin on the expression of LDL receptor in mouse macrophages. J Ethnopharmacol. 2006;105(1\u20132):251\u20134.","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"1621_CR82","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1055\/s-2008-1081316","volume":"74","author":"X Dou","year":"2008","unstructured":"Dou X, Fan C, Wo L, Yan J, Qian Y, Wo X. Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Planta Med. 2008;74(11):1374\u20139.","journal-title":"Planta Med"},{"issue":"9","key":"1621_CR83","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1210\/en.2010-0191","volume":"151","author":"Y Tang","year":"2010","unstructured":"Tang Y, Chen A. Curcumin protects hepatic stellate cells against leptin-induced activation in vitro by accumulating intracellular lipids. Endocrinology. 2010;151(9):4168\u201377.","journal-title":"Endocrinology."},{"issue":"4","key":"1621_CR84","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MOL.0b013e32832dd832","volume":"20","author":"PO Attman","year":"2009","unstructured":"Attman PO, Samuelsson O. Dyslipidemia of kidney disease. Curr Opin Lipidol. 2009;20(4):293\u20139.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"1621_CR85","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1681\/ASN.2006091006","volume":"18","author":"BC Kwan","year":"2007","unstructured":"Kwan BC, Kronenberg F, Beddhu S, Cheung AK. Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol. 2007;18(4):1246\u201361.","journal-title":"J Am Soc Nephrol"},{"key":"1621_CR86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1874192401105010041","volume":"5","author":"V Tsimihodimos","year":"2011","unstructured":"Tsimihodimos V, Mitrogianni Z, Elisaf M. Dyslipidemia associated with chronic kidney disease. Open Cardiovasc Med J. 2011;5:41\u20138.","journal-title":"Open Cardiovasc Med J"},{"issue":"6","key":"1621_CR87","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/ki.1996.515","volume":"50","author":"ND Vaziri","year":"1996","unstructured":"Vaziri ND, Liang K. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int. 1996;50(6):1928\u201335.","journal-title":"Kidney Int"},{"issue":"6","key":"1621_CR88","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/ki.1997.263","volume":"51","author":"K Liang","year":"1997","unstructured":"Liang K, Vaziri ND. Down-regulation of hepatic lipase expression in experimental nephrotic syndrome. Kidney Int. 1997;51(6):1933\u20137.","journal-title":"Kidney Int"},{"issue":"2","key":"1621_CR89","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ndt\/gfs350","volume":"28","author":"K Jin","year":"2013","unstructured":"Jin K, Norris K, Vaziri ND. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol Dial Transplant. 2013;28(2):313\u201320.","journal-title":"Nephrol Dial Transplant"},{"issue":"19","key":"1621_CR90","doi-asserted-by":"publisher","first-page":"9252","DOI":"10.1073\/pnas.89.19.9252","volume":"89","author":"S Takahashi","year":"1992","unstructured":"Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci. 1992;89(19):9252\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"42","key":"1621_CR91","doi-asserted-by":"crossref","first-page":"26411","DOI":"10.1016\/S0021-9258(18)47209-2","volume":"269","author":"EV Jokinen","year":"1994","unstructured":"Jokinen EV, Landschulz KT, Wyne KL, Ho YK, Frykman PK, Hobbs HH. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Bio Chem. 1994;269(42):26411\u20138.","journal-title":"J Bio Chem"},{"issue":"3","key":"1621_CR92","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/ki.1997.129","volume":"51","author":"ND Vaziri","year":"1997","unstructured":"Vaziri ND, Liang K. Down-regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int. 1997;51(3):913\u20139.","journal-title":"Kidney Int"},{"issue":"3","key":"1621_CR93","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4162\/nrp.2010.4.3.191","volume":"4","author":"M Kim","year":"2010","unstructured":"Kim M, Kim Y. Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet. Nutr Res Pract. 2010;4(3):191\u20135.","journal-title":"Nutr Res Pract"},{"issue":"3","key":"1621_CR94","doi-asserted-by":"publisher","first-page":"e0120950","DOI":"10.1371\/journal.pone.0120950","volume":"10","author":"ZY Li","year":"2015","unstructured":"Li ZY, Ding LL, Li JM, Xu BL, Yang L, Bi KS, et al. (1)H-NMR and MS based metabolomics study of the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet. PLoS One. 2015;10(3):e0120950.","journal-title":"PLoS One"},{"issue":"9","key":"1621_CR95","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mnfr.200700184","volume":"52","author":"KI Seo","year":"2008","unstructured":"Seo KI, Choi MS, Jung UJ, Kim HJ, Yeo J, Jeon SM, et al. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db\/db mice. Mol Nutr Food Res. 2008;52(9):995\u20131004.","journal-title":"Mol Nutr Food Res"},{"key":"1621_CR96","unstructured":"Prabu S, Sumedha, NC.: Ameliorative potential of dimethoxycurcumin: effect on lipid Profile and changes in tissue fatty acid composition in arsenic intoxicated rats. In: Advances in Dyslipidemia. edn. Telangana, India: Avid Science 2016: 2\u201323."},{"key":"1621_CR97","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1017\/S0007114512005260","volume":"109","author":"MY Um","year":"2013","unstructured":"Um MY, Moon MK, Ahn J, Youl HT. Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet. Br J Nutr. 2013;109:1590\u20137.","journal-title":"Br J Nutr"},{"issue":"3","key":"1621_CR98","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/bcpt.12076","volume":"113","author":"MY Um","year":"2013","unstructured":"Um MY, Hwang KH, Ahn J, Youl HT. Curcumin attenuates diet-induced hepatic Steatosis by activating AMP-activated protein kinase. Basic Clin Pharmacol Toxicol. 2013;113(3):152\u20137.","journal-title":"Basic Clin Pharmacol Toxicol."},{"issue":"2","key":"1621_CR99","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1001689","volume":"364","author":"AV Khera","year":"2011","unstructured":"Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. New Engl J Med. 2011;364(2):127\u201335.","journal-title":"New Engl J Med"},{"issue":"1","key":"1621_CR100","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2015.180","volume":"12","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND. HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol. 2016;12(1):37\u201347.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"1621_CR101","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1523-1755.1999.00585.x","volume":"56","author":"K Liang","year":"1999","unstructured":"Liang K, Vaziri ND. Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome. Kidney Int. 1999;56(2):621\u20136.","journal-title":"Kidney Int"},{"issue":"10","key":"1621_CR102","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/01.RES.0000250171.54048.5c","volume":"99","author":"JF Oram","year":"2006","unstructured":"Oram JF, Vaughan AM. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006;99(10):1031\u201343.","journal-title":"Circ Res"},{"issue":"1","key":"1621_CR103","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3892\/etm.2014.1717","volume":"8","author":"Y Tu","year":"2014","unstructured":"Tu Y, Sun D, Zeng X, Yao N, Huang X, Huang D, et al. Piperine potentiates the hypocholesterolemic effect of curcumin in rats fed on a high fat diet. Exp Ther Med. 2014;8(1):260\u20136.","journal-title":"Exp Ther Med"},{"issue":"5","key":"1621_CR104","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/mnfr.201100735","volume":"56","author":"JF Zhao","year":"2012","unstructured":"Zhao JF, Ching LC, Huang YC, Chen CY, Chiang AN, Kou YR, et al. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Mol Nutr Food Res. 2012;56(5):691\u2013701.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"1621_CR105","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1600-0773.1978.tb02240.x","volume":"43","author":"B Wahlstr\u00f6m","year":"1978","unstructured":"Wahlstr\u00f6m B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh). 1978;43(2):86\u201392.","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"issue":"1","key":"1621_CR106","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","volume":"46","author":"S Prasad","year":"2014","unstructured":"Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014;46(1):2\u201318.","journal-title":"Cancer Res Treat"},{"issue":"2","key":"1621_CR107","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.hermed.2015.03.001","volume":"5","author":"A Siviero","year":"2015","unstructured":"Siviero A, Gallo E, Maggini V, Gori L, Mugelli A, Firenzuoli F, Vannacci A. Curcumin, a golden spice with a low bioavailability. J Herbal Med. 2015;5(2):57\u201370.","journal-title":"J Herbal Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1621-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1621-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1621-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T10:21:20Z","timestamp":1722075680000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1621-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1621"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1621-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental design was approved by the Institutional Animal Care and Ethics Committee (Approval Number: A11259) of the Western Sydney University following the NHMRC guidelines on the \u201cAustralian Code of Practice for the Care and Use of Animals for Scientific Purposes\u201d.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"431"}}